These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 1808763

  • 1. In vitro studies on thrombin generation in citrated, r-hirudinized and heparinized whole blood.
    Kaiser B, Fareed J, Walenga JM, Hoppensteadt D, Markwardt F.
    Thromb Res; 1991 Dec 01; 64(5):589-96. PubMed ID: 1808763
    [Abstract] [Full Text] [Related]

  • 2. Thrombin-Hirudin complex formation, thrombin-antithrombin III complex formation, and thrombin generation after intrinsic activation of plasma.
    Gallistl S, Muntean W.
    Thromb Haemost; 1994 Sep 01; 72(3):387-92. PubMed ID: 7855789
    [Abstract] [Full Text] [Related]

  • 3. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T, Straub PW, Haeberli A.
    Thromb Haemost; 1994 Jan 01; 71(1):49-53. PubMed ID: 8165646
    [Abstract] [Full Text] [Related]

  • 4. Platelet functions in recombinant hirudin-anticoagulated blood.
    Glusa E, Markwardt F.
    Haemostasis; 1990 Jan 01; 20(2):112-8. PubMed ID: 2363746
    [Abstract] [Full Text] [Related]

  • 5. Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma.
    Gallistl S, Muntean W, Leis HJ.
    Thromb Haemost; 1995 Oct 01; 74(4):1163-8. PubMed ID: 8560429
    [Abstract] [Full Text] [Related]

  • 6. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
    Boisclair MD, Lane DA, Philippou H, Sheikh S, Hunt B.
    Thromb Haemost; 1993 Aug 02; 70(2):253-8. PubMed ID: 8236130
    [Abstract] [Full Text] [Related]

  • 7. Comparative studies on various assays for the laboratory evaluation of r-hirudin.
    Walenga JM, Hoppensteadt D, Koza M, Pifarre R, Fareed J.
    Semin Thromb Hemost; 1991 Apr 02; 17(2):103-12. PubMed ID: 1771408
    [Abstract] [Full Text] [Related]

  • 8. Laboratory assays for the evaluation of recombinant hirudin.
    Walenga JM, Hoppensteadt D, Koza M, Wallock M, Pifarre R, Fareed J.
    Haemostasis; 1991 Apr 02; 21 Suppl 1():49-63. PubMed ID: 1894197
    [Abstract] [Full Text] [Related]

  • 9. Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin.
    Tanaka KA, Szlam F, Sun HY, Taketomi T, Levy JH.
    Anesth Analg; 2007 Oct 02; 105(4):933-9, table of contents. PubMed ID: 17898368
    [Abstract] [Full Text] [Related]

  • 10. Platelet aggregation in recombinant-hirudin-anticoagulated blood.
    Glusa E.
    Haemostasis; 1991 Oct 02; 21 Suppl 1():116-20. PubMed ID: 1909991
    [Abstract] [Full Text] [Related]

  • 11. Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin).
    Eichinger S, Wolzt M, Schneider B, Nieszpaur-Los M, Heinrichs H, Lechner K, Eichler HG, Kyrle PA.
    Arterioscler Thromb Vasc Biol; 1995 Jul 02; 15(7):886-92. PubMed ID: 7600120
    [Abstract] [Full Text] [Related]

  • 12. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD, Weitz JI, Yusuf S, Pogue J, Sussex B, Campeau J, Gill J, Schuld R, Joyner CD, Morris AL, Lai C, Théroux P, Marquis JF, Chan YK, Venkatesh G, Jessel A.
    Eur Heart J; 2000 Sep 02; 21(17):1473-81. PubMed ID: 10952840
    [Abstract] [Full Text] [Related]

  • 13. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
    Eichinger S, Wolz M, Nieszpaur-Los M, Schneider B, Lechner K, Eichler HG, Kyrle PA.
    Thromb Haemost; 1994 Dec 02; 72(6):831-5. PubMed ID: 7740450
    [Abstract] [Full Text] [Related]

  • 14. Modulation of blood cell activation by four commonly used anticoagulants.
    Engstad CS, Gutteberg TJ, Osterud B.
    Thromb Haemost; 1997 Apr 02; 77(4):690-6. PubMed ID: 9134644
    [Abstract] [Full Text] [Related]

  • 15. Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma.
    Baier K, Cvirn G, Fritsch P, Köstenberger M, Gallistl S, Leschnik B, Muntean W.
    Pediatr Res; 2005 May 02; 57(5 Pt 1):685-9. PubMed ID: 15718352
    [Abstract] [Full Text] [Related]

  • 16. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M, Weltermann A, Nieszpaur-Los M, Schneider B, Fassolt A, Lechner K, Eichler HG, Kyrle PA.
    Thromb Haemost; 1995 Mar 02; 73(3):439-43. PubMed ID: 7667826
    [Abstract] [Full Text] [Related]

  • 17. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA, Lormeau JC, Craven S, Dewar L, Anvari N.
    Thromb Haemost; 1994 Dec 02; 72(6):862-8. PubMed ID: 7740455
    [Abstract] [Full Text] [Related]

  • 18. Markers of hemostatic system activation during thromboprophylaxis with recombinant hirudin in total hip replacement.
    Cofrancesco E, Cortellaro M, Leonardi P, Corradi A, Ravasi F, Bertocchi F.
    Thromb Haemost; 1996 Mar 02; 75(3):407-11. PubMed ID: 8701398
    [Abstract] [Full Text] [Related]

  • 19. The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma.
    Lindhout T, Blezer R, Hemker HC.
    Thromb Haemost; 1990 Nov 30; 64(3):464-8. PubMed ID: 2096492
    [Abstract] [Full Text] [Related]

  • 20. Measurement of hematological, clinical chemistry, and infection parameters from hirudinized blood collected in universal blood sampling tubes.
    Menssen HD, Brandt N, Leben R, Müller F, Thiel E, Melber K.
    Semin Thromb Hemost; 2001 Aug 30; 27(4):349-56. PubMed ID: 11547357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.